시장보고서
상품코드
2108305

유전자 계보 시장 분석 및 예측(-2035년) : 유형, 제품 유형, 서비스, 기술, 구성 요소, 용도, 최종 사용자, 솔루션, 제공 형태, 단계

Genetic Genealogy Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Solutions, Mode, Stage

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 6,690,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 8,098,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 9,507,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 유전자 계보 시장은 2025년 34억 달러에서 2035년까지 67억 달러로 확대되어 CAGR은 10.8%를 나타낼 것으로 예측됩니다. 유전자 계보 시장은 일반 소비자의 DNA 검사 및 유전체 조사 참여가 증가함에 따라 지속적으로 성장하고 있습니다. 미국 국립인간유전체연구소(NHGRI)에 따르면, DNA 염기서열 분석 비용의 감소로 인해 연구 및 상업적 용도에서의 활용이 가속화되고 있습니다. 미국 국립보건원(NIH)은 계보학 및 의학 연구에 사용되는 유전자 데이터베이스를 강화하기 위한 대규모 유전체 연구 이니셔티브를 지속적으로 지원하고 있습니다. 업계 추정에 따르면, 이 시장 규모는 2025년에 수십억 달러에 달할 것으로 보이며, 조상 검사, 법의학 조사 및 정밀의료 용도에 대한 수요 증가에 힘입어 2032년까지 두 자릿수의 연평균 성장률(CAGR)을 보일 것으로 전망됩니다.

이 시장 세분화에서는 DNA 검사 키트, 유전형 분석 서비스, 시퀀싱 서비스 및 분석 소프트웨어로 구분됩니다. DNA 검사 키트는 조상이나 친족 관계 검사를 위한 편리한 검체 채취를 가능하게 함으로써 소비자층에서의 보급을 주도하고 있습니다. 유전자형 분석 서비스는 혈통을 확인하기 위해 선택된 유전자 마커에 대한 비용 효율적인 분석을 제공하는 반면, 시퀀싱 서비스는 고급 계보학 및 조사 용도를 위한 종합적인 유전체 정보를 제공합니다. 분석 소프트웨어는 유전자 데이터 세트를 역사적 기록, 가계도 및 생물정보학 도구와 통합하여 해석의 정확도를 높입니다. 시퀀싱 기술, 인공지능, 클라우드 컴퓨팅 및 데이터베이스 통합 분야의 지속적인 발전으로 분석 정확도가 향상되고 있으며, 이는 상업, 학술, 헬스케어, 법의학 등 각 분야에서 더 광범위한 도입을 촉진하고 있습니다.

이 시장은 일반 소비자 대상 서비스, 조사 기관, 의료 제공자, 법의학 연구소를 대상으로 합니다. 조상 탐구와 가계사에 대한 관심이 높아지는 것을 배경으로, 일반 소비자 대상 서비스 이용자가 가장 큰 고객층을 차지하고 있습니다. 연구 기관에서는 집단 유전학, 이주 연구, 유전체 다양성 연구를 위해 유전자 계보를 활용하고 있습니다. 의료 서비스 제공업체는 유전성 질환 평가 및 맞춤형 의료 노력에 있어 유전적 관계에 대한 인사이트를 점점 더 많이 도입하고 있습니다. 법의학 연구소에서는 신원 미상자의 신원 확인 및 범죄 수사 지원을 위해 유전자 계보를 활용하고 있습니다. 유전체 기술에 대한 인식 제고, DNA 데이터베이스의 확충, 그리고 공공 기관과 민간 조직 간의 협력 강화로 인해 모든 최종 사용자 부문에서 수요가 확대될 것으로 예측됩니다.

지역별 개요

북미는 탄탄한 유전체 인프라, 확립된 생명공학 생태계, 그리고 DNA 검사 서비스의 소비자층에 대한 광범위한 보급을 바탕으로 유전자 계보 시장에서 주도적인 위치를 유지하고 있습니다. 이 지역은 상업적 유전자 검사 제공업체, 첨단 시퀀싱 연구소, 그리고 유전체 데이터베이스를 지속적으로 확충하고 있는 연구 기관들의 적극적인 진출로 혜택을 보고 있습니다. 정부 자금 지원 유전체 프로그램, 풍부한 연구 자금, 그리고 법의학적 유전자 계보의 활용 확대가 시장 발전을 더욱 뒷받침하고 있습니다. 높은 디지털 문해력, 조상 검사에 대한 인식 제고, 그리고 유전체 기술의 헬스케어 및 학술 연구로의 통합이 이 지역의 장기적인 시장 리더십을 더욱 공고히 하고 있습니다.

아시아태평양에서는 유전체 연구에 대한 투자 확대, 검사 시설의 역량 강화, 그리고 정밀의료 이니셔티브의 보급에 힘입어 시장이 크게 성장하고 있습니다. 이 지역 각국 정부는 헬스케어 혁신을 강화하기 위해 국가 유전체 프로젝트를 추진하고, 생명공학 인프라를 확충하고 있습니다. 가처분 소득 증가, 조상 분석에 대한 대중의 인식 제고, 그리고 합리적인 가격의 시퀀싱 서비스 이용 확대가 소비자의 참여를 촉진하고 있습니다. 학술적 협력, 생명공학에 대한 투자, 그리고 헬스케어 및 법과학 분야에서의 유전체 기술 응용 확대는 시장 성장을 지속시키는 동시에, 신흥 경제국에서 비즈니스 기회를 모색하는 전 세계 서비스 제공업체들을 유치할 것으로 예측됩니다.

주요 동향 및 성장 촉진요인

DNA 시퀀싱 기술의 발전 :

유전자 계보 시장은 DNA 시퀀싱 기술의 발전에 힘입어 눈부신 성장을 이루고 있습니다. 이러한 혁신으로 유전자 검사가 더욱 저렴해지고 소비자가 이용하기 쉬워짐에 따라, 더 폭넓은 계층이 자신의 조상을 탐구할 수 있게 되었습니다. 고속 시퀀싱 및 생물정보학 도구의 개선으로 유전자 분석의 정확도와 속도가 향상되어, 기업들은 보다 상세하고 종합적인 조상 보고서를 제공할 수 있게 되었습니다. 이러한 기술적 진보는 시장의 도달 범위와 매력을 확대하는 주요 성장 촉진요인으로 작용하고 있습니다.

유전체 기술의 보급 확대가 시장 성장을 뒷받침 :

조상의 뿌리를 탐구하려는 소비자의 관심 증가에 더해, 헬스케어 및 법의학 조사 분야에서 유전체 기술의 채택 확대가 시장 성장을 견인하고 있습니다. 시퀀싱 비용의 하락, DNA 데이터베이스의 확충, 일반 소비자용 검사 키트의 접근성 향상, 그리고 유전체 연구에 대한 정부의 지원으로 인해 상업, 임상, 연구 각 분야에서의 광범위한 활용이 촉진되는 동시에 지속적인 기술 혁신도 이루어지고 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문별 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 회사 소개

KTH 26.08.20

The global Genetic Genealogy Market is projected to grow from $3.4 billion in 2025 to $6.7 billion by 2035, at a compound annual growth rate (CAGR) of 10.8%. The Genetic Genealogy Market continues to expand alongside increasing public participation in consumer DNA testing and genomic research. According to the National Human Genome Research Institute (NHGRI), the declining cost of DNA sequencing has accelerated accessibility for research and commercial applications. The U.S. National Institutes of Health (NIH) continues to support large-scale genomics initiatives that strengthen genetic databases used in genealogy and medical research. Industry estimates indicate the market is valued at several billion U.S. dollars in 2025 and is projected to register a double-digit CAGR through 2032, supported by rising demand for ancestry testing, forensic investigations, and precision healthcare applications.

The market is segmented into DNA Test Kits, Genotyping Services, Sequencing Services, and Analysis Software. DNA test kits dominate consumer adoption by enabling convenient sample collection for ancestry and relationship testing. Genotyping services provide cost-effective analysis of selected genetic markers for lineage identification, while sequencing services deliver comprehensive genomic information for advanced genealogical and research applications. Analysis software integrates genetic datasets with historical records, family trees, and bioinformatics tools to improve interpretation accuracy. Continuous advancements in sequencing technologies, artificial intelligence, cloud computing, and database integration are expanding analytical precision, supporting broader adoption across commercial, academic, healthcare, and forensic environments.

Market Segmentation
TypeAutosomal DNA Testing, Y-DNA Testing, mtDNA Testing, X-DNA Testing, Others
ProductDNA Test Kits, Genetic Ancestry Kits, Genealogy Software, Others
ServicesAncestry Analysis, Genetic Counseling, Data Interpretation, Others
TechnologyNext-Generation Sequencing, Microarray, Polymerase Chain Reaction, Others
ComponentHardware, Software, Services, Others
ApplicationPersonal Ancestry, Forensic Research, Medical Research, Paternal Lineage, Maternal Lineage, Others
End UserIndividuals, Research Institutions, Healthcare Providers, Forensic Laboratories, Genealogy Societies, Others
SolutionsFamily Tree Building, Ethnicity Estimation, Genetic Health Risk Assessment, Others
ModeOnline Platforms, Direct-to-Consumer, Professional Services, Others
StageData Collection, Data Analysis, Data Interpretation, Others

The market serves Direct-to-Consumer, Research Institutes, Healthcare Providers, and Forensic Laboratories. Direct-to-consumer users represent the largest customer base, driven by increasing interest in ancestry exploration and family history. Research institutes utilize genetic genealogy for population genetics, migration studies, and genomic diversity research. Healthcare providers increasingly incorporate genetic relationship insights into hereditary disease assessment and personalized medicine initiatives. Forensic laboratories employ genetic genealogy to identify unknown individuals and support criminal investigations. Growing awareness of genomic technologies, expanding DNA databases, and increasing collaboration between public institutions and private organizations are expected to strengthen demand across all end-user segments.

Geographical Overview

North America maintains a leading position in the Genetic Genealogy Market due to its extensive genomics infrastructure, established biotechnology ecosystem, and widespread consumer adoption of DNA testing services. The region benefits from strong participation by commercial genetic testing providers, advanced sequencing laboratories, and research institutions that continuously expand genomic databases. Government-funded genomics programs, favorable research funding, and growing utilization of forensic genetic genealogy further strengthen market development. High digital literacy, increasing awareness of ancestry testing, and integration of genomic technologies into healthcare and academic research continue to reinforce long-term regional market leadership.

Asia-Pacific is witnessing substantial expansion supported by increasing investments in genomics research, improving laboratory capabilities, and broader adoption of precision medicine initiatives. Governments across the region are promoting national genome projects and expanding biotechnology infrastructure to strengthen healthcare innovation. Rising disposable incomes, growing public awareness of ancestry analysis, and expanding availability of affordable sequencing services are encouraging consumer participation. Academic collaborations, biotechnology investments, and increasing application of genomic technologies in healthcare and forensic science are expected to sustain market expansion while attracting global service providers seeking opportunities in emerging economies.

Key Trends and Drivers

Technological Advancements in DNA Sequencing:

The genetic genealogy market is experiencing significant growth due to advancements in DNA sequencing technologies. These innovations have made genetic testing more affordable and accessible to consumers, enabling a wider demographic to explore their ancestry. High-throughput sequencing and improved bioinformatics tools have enhanced the accuracy and speed of genetic analysis, allowing companies to offer more detailed and comprehensive ancestry reports. This technological progress is a key driver in expanding the market's reach and appeal.

Expanding Genomics Adoption Fueling Market Growth:

Growing consumer interest in ancestry discovery, combined with increasing adoption of genomic technologies in healthcare and forensic investigations, is driving market expansion. Declining sequencing costs, expanding DNA databases, greater accessibility of direct-to-consumer testing kits, and government support for genomics research are encouraging widespread utilization across commercial, clinical, and research applications while fostering continuous technological innovation.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Mode
  • 2.9 Key Market Highlights by Stage
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Autosomal DNA Testing
    • 4.1.2 Y-DNA Testing
    • 4.1.3 mtDNA Testing
    • 4.1.4 X-DNA Testing
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 DNA Test Kits
    • 4.2.2 Genetic Ancestry Kits
    • 4.2.3 Genealogy Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Ancestry Analysis
    • 4.3.2 Genetic Counseling
    • 4.3.3 Data Interpretation
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Next-Generation Sequencing
    • 4.4.2 Microarray
    • 4.4.3 Polymerase Chain Reaction
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Personal Ancestry
    • 4.5.2 Forensic Research
    • 4.5.3 Medical Research
    • 4.5.4 Paternal Lineage
    • 4.5.5 Maternal Lineage
    • 4.5.6 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Individuals
    • 4.6.2 Research Institutions
    • 4.6.3 Healthcare Providers
    • 4.6.4 Forensic Laboratories
    • 4.6.5 Genealogy Societies
    • 4.6.6 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Mode (2020-2035)
    • 4.8.1 Online Platforms
    • 4.8.2 Direct-to-Consumer
    • 4.8.3 Professional Services
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Stage (2020-2035)
    • 4.9.1 Data Collection
    • 4.9.2 Data Analysis
    • 4.9.3 Data Interpretation
    • 4.9.4 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Family Tree Building
    • 4.10.2 Ethnicity Estimation
    • 4.10.3 Genetic Health Risk Assessment
    • 4.10.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Mode
      • 5.2.1.9 Stage
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Mode
      • 5.2.2.9 Stage
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Mode
      • 5.2.3.9 Stage
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Mode
      • 5.3.1.9 Stage
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Mode
      • 5.3.2.9 Stage
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Mode
      • 5.3.3.9 Stage
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Mode
      • 5.4.1.9 Stage
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Mode
      • 5.4.2.9 Stage
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Mode
      • 5.4.3.9 Stage
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Mode
      • 5.4.4.9 Stage
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Mode
      • 5.4.5.9 Stage
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Mode
      • 5.4.6.9 Stage
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Mode
      • 5.4.7.9 Stage
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Mode
      • 5.5.1.9 Stage
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Mode
      • 5.5.2.9 Stage
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Mode
      • 5.5.3.9 Stage
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Mode
      • 5.5.4.9 Stage
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Mode
      • 5.5.5.9 Stage
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Mode
      • 5.5.6.9 Stage
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Mode
      • 5.6.1.9 Stage
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Mode
      • 5.6.2.9 Stage
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Mode
      • 5.6.3.9 Stage
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Mode
      • 5.6.4.9 Stage
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Mode
      • 5.6.5.9 Stage
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 23andMe
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Ancestry
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 MyHeritage
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 FamilyTreeDNA
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Living DNA
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Findmypast
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Gene by Gene
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 GenoPalate
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 African Ancestry
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Helix
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 DNAfit
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Veritas Genetics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Full Genomes Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Pathway Genomics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Genetic Direction
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Mapmygenome
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 GenePlanet
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Xcode Life
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 TellmeGen
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 EasyDNA
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기